Bleeding and Clotting Disorders
Protocol:ALN-AT3SC-003
Condition or Disease: Hemophilia A or B
Study Type: Interventional (Clinical Trial)
Status: Open for enrollment
Study Title: ATLAS-INH: A Phase 3 Study to Evaluate the Efficacy and Safety of Fitusiran in Patients with Hemophilia A or B, with Inhibitory Antibodies to Factor VIII or IX
Principal I investigator: Joseph Lasky III, MD
More Info: //clinicaltrials.gov/ct2/show/NCT03417102
